212 related articles for article (PubMed ID: 20176908)
1. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.
Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA
Antimicrob Agents Chemother; 2010 May; 54(5):1734-41. PubMed ID: 20176908
[TBL] [Abstract][Full Text] [Related]
2. Pilot Study of the Pharmacokinetics of Cefotaxime in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy.
Koedijk JB; Valk-Swinkels CG; Rijpstra TA; Touw DJ; Mulder PG; van der Voort PH; van 't Veer NE; van der Meer NJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3587-90. PubMed ID: 27021325
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.
Béranger A; Oualha M; Urien S; Genuini M; Renolleau S; Aboura R; Hirt D; Heilbronner C; Toubiana J; Tréluyer JM; Benaboud S
Clin Pharmacokinet; 2018 Jul; 57(7):867-875. PubMed ID: 28980166
[TBL] [Abstract][Full Text] [Related]
4. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.
Amaker RD; DiPiro JT; Bhatia J
Antimicrob Agents Chemother; 1996 May; 40(5):1139-42. PubMed ID: 8723454
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefotaxime in preterm infants.
Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
[TBL] [Abstract][Full Text] [Related]
8. Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates.
Kearns GL; Jacobs RF; Thomas BR; Darville TL; Trang JM
J Pediatr; 1989 Mar; 114(3):461-7. PubMed ID: 2921690
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.
Ahsman MJ; Hanekamp M; Wildschut ED; Tibboel D; Mathot RA
Clin Pharmacokinet; 2010 Jun; 49(6):407-19. PubMed ID: 20481651
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.
Maksoud E; Koehl B; Facchin A; Ha P; Zhao W; Kaguelidou F; Benkerrou M; Mariani P; Faye A; Lorrot M; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378711
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn.
Aujard Y; Brion F; Jacqz-Aigrain E; Kasse MC; Chretien P; Criqui C; Mathieu H
Diagn Microbiol Infect Dis; 1989; 12(1):87-91. PubMed ID: 2653716
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation.
Bourgoin P; Lecomte J; Oualha M; Berthomieu L; Pereira T; Davril E; Lamoureux F; Joram N; Chenouard A; Duflot T
Clin Pharmacokinet; 2023 Feb; 62(2):335-348. PubMed ID: 36631687
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.
Nandy P; Samtani MN; Lin R
Antimicrob Agents Chemother; 2010 Jun; 54(6):2354-9. PubMed ID: 20385854
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
[TBL] [Abstract][Full Text] [Related]
15. Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation.
Sinnah F; Shekar K; Abdul-Aziz MH; Buscher H; Diab SD; Fisquet S; Fung YL; McDonald CI; Reynolds C; Rudham S; Wallis SC; Welch S; Xie J; Fraser JF; Roberts JA;
Crit Care Resusc; 2017 Oct; 19(Suppl 1):8-14. PubMed ID: 29084496
[TBL] [Abstract][Full Text] [Related]
16. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation.
Watt KM; Gonzalez D; Benjamin DK; Brouwer KL; Wade KC; Capparelli E; Barrett J; Cohen-Wolkowiez M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3935-43. PubMed ID: 25896706
[TBL] [Abstract][Full Text] [Related]
18. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
[TBL] [Abstract][Full Text] [Related]
19. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
[TBL] [Abstract][Full Text] [Related]
20. Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants.
Chen XK; Shi HY; Leroux S; Xu HY; Zhou Y; Zheng Y; Huang X; Li Y; Jacqz-Aigrain E; Zhao W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
